Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells

Cancer Research

Volumn 56, Issue 24, 1996, Pages 5638-5646

  Siders, William M ^a   Halloran, Patrick J ^a   Fenton, Robert G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; MONOPHENOL MONOOXYGENASE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; ENHANCER REGION; GENE CASSETTE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PIGMENT CELL; PRIORITY JOURNAL; PROMOTER REGION; TANDEM REPEAT; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; ENZYME ACTIVATION; GENES, REPORTER; GENETIC VECTORS; HUMANS; MELANOMA; MICE; MONOPHENOL MONOOXYGENASE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029730701     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Crystal, R. G Transfer of genes to humans: early lessons and obstacles to success. Science (Washington DC), 270: 404-410, 1995.
2. Kasahara, N., Dozy, A. M., and Kan, Y. W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions Science (Washington DC), 266: 1373-1375, 1994.
3. Somia, N. V., Zoppe, M., and Verma, I. M. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl. Acad. Sci. USA, 92: 7570-7574, 1995.
4. Slamon, D. J., Godolphin, W., Jones, L A., Holt, J. A , Wong, S. G , Keith, D. E., Levin, W. J., Stuart, S. G , Udove, J , Ullrich, A., and Press, M. F Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
5. D3, a prominent ganglioside of human melanoma. J. Exp. Med , 155: 1133-1147, 1982
6. Taylor-Papadimitriou, J Report on the first international workshop on carcinoma-associated mucins. Int. J. Cancer, 49: 1-5, 1991.
7. Hart, I. Tissue specific promoters in targeting systemically delivered gene therapy. Semin. Oncol., 23: 154-158, 1996
8. Osaki, T., Tanio, Y., Tachibana, I., Hosoe, S , Kumagai, T., Kawase, I., Oikawa, S., and Kishimoto, T Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res., 54: 5258-5261, 1994.
9. Richards, C. A., Autsin, E. A., and Huber, B. E. Transcriptional regulatory sequences of carcinoembryonic antigen identification and use with cytosine deaminase for tumor-specific gene therapy. Hum Gene Ther., 6: 881-893, 1995.
10. Smith, M. J , Rousculp, M. D., Goldsmith, K. T., Curiel, D. T., and Garver, R I. Surfactant protein A-directed toxin gene kills lung cancer cells in vitro. Hum Gene Ther., 5 29-35, 1994.
11. Manome, Y , Abe, M., Hagen, M F, Fine, H. A., and Kufe, D. W Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to gancyclovir Cancer Res., 54: 5408-5413, 1994.
12. Huber, B. E., Richards, C. A , and Krenitsky, T. A. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl. Acad Sci USA, 88: 8039-8043, 1991
13. Ido, A , Nakata, K , Kato, Y., Nakao, K , Murata, K., Fujita, M., Ishii, N , Tamaoki, T., Shiku, H , and Nagataki, S. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter. Cancer Res, 55: 3105-3109, 1995
14. Kaneko, S., Hallenbeck, P. Kotani, T. Nakabayashi, H., McGarrity G., Tamaoki, T., Anderson, W. F., and Chiang, Y. L Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res., 55: 5283-5287, 1995.
15. Vile, R. G., and Hart, I. R. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res., 53: 962-967, 1993.
16. Rosenberg, S. A. The immunotherapy and gene therapy of cancer. J Clin Oncol , 10: 180-199, 1992.
17. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F , Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347-352, 1994.
18. Rosenberg, S A., and White, D. E. Vitiligo in patients with melanoma, normal tissue antigens can be targets for cancer immunotherapy. J. Immunother , 19: 81-84, 1996.
19. Beermann, F, Rupport, S , Hummler, E., Bosch, F. X , Muller, G , Ruther, U , and Schutz, G Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice. EMBO J., 9: 2819-2826, 1990.
20. Tanaka, S , Yamamoto, H., Takeuchi, S., and Takeuchi, T. Melanization in albino mice by introducing cloned mouse tyrosinase gene Development (Camb.), 108: 223-227, 1990.
21. Kluppel, M , Beermann, F., Ruppert, S., Schmid, E., Hummler, E., and Schutz, G. The mouse tyrosinase promoter is sufficient for expression in melanocytes and in the pigmented epithelium of the retina. Proc Natl. Acad. Sci. USA, 88: 3777-3781, 1991.
22. Shibata, K , Muraosa, Y , Tomita, Y., Tagami, H., and Shibahara, S. Identification of a cis-acting element that enhances the pigment cell-specific expression of the human tyrosinase gene. J. Biol. Chem., 207: 20584-20588, 1992.
23. Tanaka, M., Tanaka, S . Miura, H., Yamamoto, H , Kikuchi, H., and Takeuchi, T. Conserved regulatory mechanisms of tyrosinase genes in mice and humans. Pigm. Cell Res., 5: 304-311, 1992.
24. Bentley, N. J., Eisen, T., and Goding, C. R. Melanocyte-specific expression of the human tyrosinase promoter, activation by the microphthalmia gene product and role of the initiator. Mol. Cell Biol , 14: 7996-8006, 1994
25. Ganss, R., Schutz, G., and Beerman, R. The mouse tyrosinase gene. J. Biol. Chem , 269: 29808-29816, 1994
26. Ganss, R , Montoliu, L , Monaghan, A. P , and Schutz, G A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice. EMBO J., 13: 3083-3093, 1994.
27. Ponnazhagan, S., Hou, L., and Kwon, B S. Structural organization of the human tyrosinase gene and sequence analysis and characterization of its promoter region J. Invest. Dermatol., 102: 744-748, 1994.
28. Hitt, M., Bett, A. J , Addison, C. L., Prevec, L., and Graham, F. L. Techniques for human adenovirus vector construction and characterization. In: K W. Adolph (ed.), Methods in Molecular Genetics, Vol. 7, pp. 13-30. Orlando, FL. Academic Press, Inc., 1995.
29. Bett, A. J., Hadarra, W., Prevec, L , and Graham, F. L. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci USA, 91: 8802-8806, 1994.
30. Yasumoto, K-I., Yokoyami, K , Shibata, K., Tomita, Y , and Shibahara, S. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol. Cell. Biol., 14: 8058-8070, 1994.
31. Lowings, P , Yavuzer, U , and Goding, C. R. Positive and negative elements regulate a melanocyte-specific promoter. Mol. Cell. Biol., 12: 3653-3662, 1992.
32. Lasser, A. B., Davis, R. L., Wright, W. E., Kadesch, T., Murre, C., Voronova, A, Baltimore, D , and Weintraub, H. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell, 66: 305-315, 1991.
33. Yavuzer, U , and Goding, C R Melanocyte-specific gene expression role of repression and identification of an melanocyte-specific factor, MSF. Mol Cell. Biol., 14: 3494-3503, 1994.
34. Hodgkinson, C. A., Moore, K. J., Nakayama, A , Steingrimsson, E., Copeland, N G., Jenkins, N. A., and Amheiter, H Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell, 74: 395-404, 1993
35. Hughes, M. J., Lingrel, J B., Krakowsky, J. M., and Anderson, K. P A helix-loop-helix transcription factor-like gene is located at the mi locus J Biol. Chem., 268: 20687-20690, 1993
36. Hemesath. T J. Steingrimsson, E., McGill, G., Hansen, M. J., Vaught, J., Hodgkinson, C. A., Arnheiter, H., Copeland, N G., Jenkins, N. A , and Fisher, D E Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev , 8: 2770-2780, 1994.
37. Tachibana, M., Perez-Jurado, L A., Nakayama, A., Hodgkinson, C A., Li, X., Schneider, M., Miki, T., Fex, J., Franke, U., and Arnheiter, H Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3 Hum. Mol. Genet , 3: 553-557, 1994
38. Tasabehji, M., Newton, V E., and Read, A. P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet., 8: 251-255, 1994.
39. Artandi, S. E , Cooper, C., Shrivastava, A., and Calame, K The basic helix-loop-helix-zipper domain of TFE3 mediates enhancer-promoter interaction. Mol. Cell. Biol. 14: 7704-7716, 1994.
40. Schmidt, E. V , Christoph, G. Zeller, R., and Leder, P. The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol. Cell Biol., 10 4406-4411, 1990.
41. Furth, P. A., Hennighausen, L., Baker, C , Beatty, B., and Woychick, R The variability of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice Nucleic Acids Res., 19: 6205-6208, 1991.
42. Hearing, P., and Shenk, T. The adenovirus type 5 E1A enhancer contains two functionally distinct domains, one is specific for E1A and the other modulates all early units in cis. Cell. 45 229-236, 1986.
43. Yoshida, K., Higashino, F , and Fujinaga, K. Transcriptional regulation of the adenovirus E1A gene In W Doerfler and P. Bohm (eds), The Molecular Repertoire of Adenoviruses III. pp 113-130 New York: Springer Publishing Co , 1995.
44. Takana, T., Kanai, F., Okabe, S., Yoshida, Y , Wakimoto, H , Hamada, H., Shiratori, Y , Lan, K-H, Ishitobi, M., and Omata, M. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. Cancer Res , 56: 1341-1345, 1996.
45. Greenberg, N. M., DeMayo, F., Finegold, M J., Medina, D , Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A A , Matusik R. J , and Rosen, J. M Prostate cancer in a transgenic mouse. Proc. Natl Acad Sci USA, 92: 3439-3443, 1995
46. Vile, R G., Nelson, J A., Castleden, S., Chong, H., and Hart, I R. Systemic gene therapy of murine melanoma using tissue-specific expression the the HSVtk gene involves an immune component. Cancer Res., 54: 6228-6234, 1994.
47. Chen, S-H., Li Chen, X H., Wang, Y , Kosai, K-I, Finegold, M J., Rich, S S., and Woo, S L. C Combination gene therapy for liver metastasis of colon carcinoma Proc. Natl. Acad. Sci. USA, 92: 2577-2581, 1995.